Cardlytics shareholders approve 2025 Equity Incentive Plan authorizing up to 15.7M shares

Cardlytics, Inc.

Plan authorizes 15,722,908 shares: 10M new shares plus prior plan reserves and returning shares.
Annual meeting results: Class I directors elected (Jon Francis, Scott Hill, Alex Mishurov).
Deloitte & Touche ratified as independent auditor for fiscal year 2025.
Non-binding advisory vote on named executive officer compensation approved.
Plan became effective immediately upon stockholder approval on May 20, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.